Philip Morris International Stock
Philip Morris International gained 0.630% compared to yesterday.
Our community is currently high on Philip Morris International with 3 Buy predictions and 0 Sell predictions.
With a target price of €92.00 there is a slightly positive potential of 6.481% for Philip Morris International compared to the current price of €86.40.
Pros and Cons of Philip Morris International in the next few years
Pros
?
Conscious of the environment
?
Worthwhile Investment for the next years
?
Growth compared to competition
Cons
?
Shareholder structure
?
Brand
?
Market Position
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Philip Morris International vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Philip Morris International | 0.630% | -2.408% | -0.877% | 30.637% | 28.277% | 20.454% | -5.061% |
| Altria Group Inc. | 1.190% | -1.032% | -0.483% | 25.311% | 23.770% | -22.437% | -28.071% |
| Japan Tobacco Inc ADR | -0.610% | 0.000% | 1.875% | 5.161% | 1.875% | -25.435% | -54.467% |
| British American Tobacco PLC | 0.160% | 0.475% | -0.627% | 6.215% | 2.028% | -21.902% | -44.705% |
Comments
Other discussions about Philip Morris International Stock
Trading Philip Morris International
Trading Philip Morris International
News
Science, Innovation, and Inclusion Are Vital in Addressing the World’s Most Pressing Issues, Says PMI CEO in Speech at Concordia Summit
Jacek Olczak, Chief Executive Officer of Philip Morris International Inc. (PMI) (NYSE: PM), today delivered remarks at the 2021 Concordia Annual Summit. Olczak discussed the need to draw on the
Philip Morris International Announces Unconditional Offer for Vectura Group PLC
PMI Global Services Inc. (PMI) (NYSE: PM) today announced that its offer for Vectura Group plc (Vectura) (LSE: VEC) has become unconditional, having received valid acceptances for or acquired 74.77
Philip Morris International Announces Closing of Fertin Pharma Acquisition; Advances PMI’s Goal of Becoming a Majority Smoke-Free Business by 2025 and Creates Growth Opportunities Beyond Nicotine
Regulatory News:
Philip Morris International Inc. (PMI) (NYSE: PM) today announced the closing of its acquisition of Fertin Pharma A/S (“Fertin Pharma”), a leading developer and manufacturer of
